Although the effects of PBDEs on different cell lines have been showed to vary, our results agree with the previously described in hepatoma HepG2 cells and Neuro-2a cells, in which the treatment determined an increase of ROS [68] accompanied by a modulation of the Nrf-2 pathway [52]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.